USD 114.36 billion
Global Pharmaceutical Contract Development and Manufacturing Market Size, Share, Growth Analysis, By Service(Pharmaceutical Manufacture, Drug Development), By End user(Large pharmaceutical firms, small & mid-size pharmaceutical companies) - Industry Forecast 2024-2031
Report ID:
SQMIG35J2034 |
Region:
Global |
Published Date: February, 2024
Pages:
242
|
Tables:
63 |
Figures:
75
Global Pharmaceutical Contract Development and Manufacturing Market Insights
Pharmaceutical Contract Development and Manufacturing Market size was valued at USD 114.36 billion in 2019 and is poised to grow from USD 122.25 billion in 2023 to USD 222.87 billion by 2031, growing at a CAGR of 6.9% in the forecast period (2024-2031).
Pharmaceutical contract development and manufacturing firms provide a range of services to small and large pharmaceutical enterprises under a contract. These services include the production of final dosage forms (FDFs), active ingredients (APIs), drug research & drug discovery services, and biologics. Manufacturers' increasing propensity to use cutting-edge technologies, the expiration of drug patents, rising investments in R&D, the rise in demand for generic medications & biologics, and the COVID-19 pandemic are all factors that have contributed to the growth of the market. Additionally, the market is anticipated to expand because of the rising need for cell and gene treatments, customised medicines, high potency active pharmaceutical ingredients (HPAPIs), and antibody-drug conjugates (ADCs). The adoption of serialisation and a dearth of qualified specialists are two obstacles to this market's expansion, nevertheless.
US Pharmaceutical Contract Development and Manufacturing Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Pharmaceutical Manufacture
Fastest Growth
Pharmaceutical Manufacture
Growth Rate
6.9% CAGR
Global Pharmaceutical Contract Development and Manufacturing Market ($ Bn)
Country Share for North America Region (%)
Global Pharmaceutical Contract Development and Manufacturing Market By Service ($ Bn)
Global Pharmaceutical Contract Development and Manufacturing Market By Service (%)
To get more reports on the above market click here to Buy The Report
Global Pharmaceutical Contract Development and Manufacturing Market Segmental Analysis
Pharmaceutical Contract Development and Manufacturing Market Analysis by service
The pharmaceutical contract development and manufacturing market is anticipated to be dominated by the pharmaceutical manufacturing services segment in 2022. The huge market share of this sector is related to the expanding need for the industry to lower manufacturing costs, the expanding demand for high-quality bulk manufacturing, and the expanding need for generic medications. However, it is anticipated that during the projected period, the category for biologics manufacturing services will develop at the highest CAGR.
Pharmaceutical Contract Development and Manufacturing Market Analysis by end user
Large firms, small & mid-size companies, and generic pharmaceutical companies make up the three segments of the industry based on end users. The market is anticipated to be dominated by large companies in 2022. The significant market share of this sector is linked to the rising global demand from businesses, the growing demand for cutting-edge production techniques and technologies, and the pharmaceutical industry's ongoing efforts to cut production costs.
Global Pharmaceutical Contract Development and Manufacturing Market By Service, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Pharmaceutical Contract Development and Manufacturing Market Regional Insights
The pharmaceutical contract development and manufacturing market is anticipated to be dominated by North America in 2022, followed by Europe and Asia-Pacific. The substantial share of this region is primarily linked to expanding generic medicine and biologics demand, CDMO consolidation, rising need for biosimilars due to patent expiry, and rising outsourcing costs. Furthermore, the focus on pharmaceutical and biotechnology research by organisations has made the contract manufacturing business in North America extremely competitive.
However, during the forecast period, Asia-Pacific is expected to have the greatest CAGR. With a revenue share of more than 40%, Asia Pacific dominated the market and is anticipated to expand significantly over the forecast period. This expansion is made possible by an increase in the number of businesses outsourcing work to these nations' emerging economies. Due to their growing production capacities, nations like Singapore, China, and India have recently been recognised as key players in the pharmaceutical sector. The Asian businesses' plenty of cash is to blame for the contract manufacturing industry's monopolistic nature. Significant investments from Asian CMOs are anticipated to spur exponential growth. Due to the presence of well-established multinational players in this area, the Latin American market is predicted to grow significantly over the course of the forecast period. Novartis, Roche, and Pfizer are three significant companies with operations in Brazil. Latin America has the potential to emerge into a major global centre for the creation of pharmaceutical goods. This shift is the result of several factors, including the cheap cost of product creation.
Global Pharmaceutical Contract Development and Manufacturing Market By Region, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Pharmaceutical Contract Development and Manufacturing Market Dynamics
Pharmaceutical Contract Development and Manufacturing Market Drivers
Rise in Need for Pharmaceuticals for Chronic Illness to Boost Market Growth
- The market is being driven by the advantages of outsourcing, namely the savings in time and money. To increase their share of outsourcing revenue, market players frequently spend on infrastructure, staff, and technology.
- The rising prevalence of chronic diseases among the world's population and the steadily growing global human population are the main factors impacting the market’s high growth potential in the years to come. The need for improved production capacity in the pharmaceuticals industry is being driven by the increase in chronic illnesses of all types, including cancer, cardiovascular disease, and infectious diseases.
Pharmaceutical Contract Development and Manufacturing Market Restraints
Shortage of Skilled Labor to Hinder Market Growth
- Lack of process understanding can occasionally result in a defective product line and damage consumer confidence, risking the agreement between developers, producers, and sellers.
Request Free Customization of this report to help us to meet your business objectives.
Global Pharmaceutical Contract Development and Manufacturing Market Competitive Landscape
To improve their market position, players in the industry are concentrating on agreements, partnerships, collaborations, acquisitions, and other tactics. Pharma firms must provide more and better new pharmaceuticals to combat the diseases to which the human body is susceptible in order to combat the rising number of new diseases.
Pharmaceutical Contract Development and Manufacturing Market Top Player's Company Profiles
-
Lonza Group AG
-
Thermo Fisher Scientific, Inc.
-
Boehringer Ingelheim GmbH
-
Evonik Industries AG
-
Recipharm AB
-
Vetter Pharma International GmbH
-
WuXi AppTec Co. Ltd.
-
Famar Health Care Services
-
Almac Group
-
Jubilant Life Sciences Limited
-
Samsung BioLogics
-
PRA Health Sciences
-
Cambrex Corporation
-
Ajinomoto Bio-Pharma Services
-
Syneos Health
-
Mylan N.V.
-
AMRI Global
-
Baxter BioPharma Solutions
Pharmaceutical Contract Development and Manufacturing Market Recent Developments
- In February 2022, Recipharm AB (Sweden) acquired Arranta Bio (U.S.) to add scientifically differentiated contract development and manufacturing services for ATMPs in its service offerings and develop a strong presence in the U.S.
- In February 2021, Charles River Laboratories International, Inc. (U.S.) acquired Cognate BioServices, Inc. (U.S.) for $875 million to add cell and gene therapy CDMO capabilities.
Global Pharmaceutical Contract Development and Manufacturing Key Market Trends
- With the rise in cancer incidence and the creation of safe and efficient medications thanks to technical advancements, the market for oncology treatments has expanded quickly. Because of the growing demand for potent, focused medicines and the ability of compounds to be more selective towards the target of interest to reduce dosing frequencies, there is an increasing interest in highly potent New Chemical Entities (NCEs).
- The bigger CMOs are adopting the pattern of shifting their attention to the specialised fields of pharmaceutical development. They are concentrating on creating regulatory mechanisms for the creation of transgenic-based products. Companies are, nevertheless, ready to limit outsourcing when producing large and complex components. They believe that internal production is preferable to outsourcing because of the unique requirements. This could be a hurdle for the market as a result.
Global Pharmaceutical Contract Development and Manufacturing Market SkyQuest Analysis
SkyQuest’s ABIRAWA (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global pharmaceutical contract development and manufacturing market analysis, The market is expanding quickly as a result of mounting pressure on key industry players, difficulties in the pharmaceutical industry's development process, an increasing number of patents expiring, an increase in the prevalence of chronic diseases, and rising R&D costs. Governments around the world are placing more emphasis on improving the quality of life for the geriatric population, which is leading to an increase in geriatric drug clinical trials, increased attention to domestic active API manufacturers even in developed nations, and the establishment of contract manufacturing organisations (CMOs) in emerging economies. In the upcoming years, these factors are most likely to increase demand in the global market. Additionally, the worldwide pharmaceutical contract manufacturing market is expanding due to the rising demand from the oncology sector.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 114.36 billion |
| Market size value in 2031 | USD 222.87 billion |
| Growth Rate | 6.9% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
| Historical Year | 2019 |
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Pharmaceutical Contract Development and Manufacturing Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Pharmaceutical Contract Development and Manufacturing Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Pharmaceutical Contract Development and Manufacturing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Pharmaceutical Contract Development and Manufacturing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Pharmaceutical Contract Development and Manufacturing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Pharmaceutical Contract Development and Manufacturing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Pharmaceutical Contract Development and Manufacturing Market Report Snapshots
- Global Pharmaceutical Contract Development and Manufacturing Companies
- Global Pharmaceutical Contract Development and Manufacturing Market Size
- Global Pharmaceutical Contract Development and Manufacturing Market Analysis
- Global Pharmaceutical Contract Development and Manufacturing Geographic Analysis
- Global Pharmaceutical Contract Development and Manufacturing Market News
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
